HIT Consultant October 11, 2024
What You Should Know:
– Cytovale, a medical diagnostics company revolutionizing early disease detection secures $100M in Series D funding round led by Sands Capital with participation from new investor Canada Pension Plan Investment Board (CPP Investments) and existing investors.
– The investment will fuel the expansion of Cytovale’s innovative sepsis diagnostic, IntelliSep, to more hospital emergency departments (EDs) and health systems nationwide.
IntelliSep: Transforming Sepsis Detection in the Emergency Department
Sepsis, a life-threatening condition caused by the body’s overwhelming response to infection, often presents in the emergency department (ED). IntelliSep is the first and only FDA-cleared cellular host diagnostic specifically designed for use in the ED, where over 80% of sepsis cases initially appear.
This innovative test...
Today's Sponsors
Today's Sponsor